TGFB1 and hepatocellular carcinoma: The observation that TGF-β is capable of upregulating CD133 expression within the Huh-7 hepatocellular carcinoma cells in a time- and dose-dependent manner suggests a relationship between TGF-β signalization and CD133 expression [40].